Ladenburg Thalmann Starts Quoin Pharmaceuticals (QNRX) at Buy

Ladenburg Thalmann analyst Aydin Huseynov initiates coverage on Quoin Pharmaceuticals (NASDAQ: QNRX) with a Buy rating and a price target of $2.00.

For an analyst ratings summary and ratings history on Quoin Pharmaceuticals click here. For more ratings news on Quoin Pharmaceuticals click here.

Shares of Quoin Pharmaceuticals closed at $0.81 yesterday.

You May Also Be Interested In

• Quoin Pharmaceuticals Doses First Patient in Open Label Netherton Syndrome Clinical Trial
• Citi Resumes SACI Falabella (FALAB:CI) at Neutral
• Credit Suisse Assumes Prysmian SpA (PRY:IM) (PRYMY) at Outperform